Anti dermatophytic therapy - Prospects for the discovery of new drugs from natural products

Brazilian Journal of Microbiology

Volumn 44, Issue 4, 2013, Pages 1035-1041

  Soares, Luciana Arantes ^a   Sardi, Janaína de Cássia Orlandi ^a   Gullo, Fernanda Patrícia ^a   Pitangui, Nayla de Souza ^a   Scorzoni, Liliana ^a   Leite, Fernanda Sangalli ^a   Giannini, Maria José Soares Mendes ^a   Almeida, Ana Marisa Fusco ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Dermatophytes; Filamentous fungi; Natural products; Synthetic product

Indexed keywords

ANTIFUNGAL AGENT; BIOLOGICAL PRODUCT;

ARTHRODERMATACEAE; DRUG DEVELOPMENT; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; TINEA; TRENDS;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; BIOLOGICAL PRODUCTS; DRUG DISCOVERY; HUMANS; TINEA;

EID: 84897429673     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822014005000011     Document Type: Review

References (74)

1. Abdel-Rahman SM (2001) Polymorphic exocellular protease expression in clinical isolates of Trichophyton tonsurans. Mycopathologia. 150:117-120.
2. Abdel-Rahman SM, Nahata MC (1997) Oral terbinafine: a new antifungal agent. Ann Pharmacother 31: 445-456.
3. Abdel-Rahman SM, Powell DA, Nahata MC (1998) Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. J Am Acad Dermatol 38:443-446.
4. Akcaglar S., Ener B, Toker SC, Ediz B, Tunali S, Tore O (2011) A comparative study of dermatophyte infections in Bursa, Turkey. Med Mycol 49:602-607.
5. Alanís-Garza BA, González-González GM, Salazar-Aranda R, Waksman de Torres N, Rivas-Galindo VM (2007) Screening of antifungal activity of plants from the northeast of Mexico. J Ethnopharmacol 114:468-471.
6. Baeza L. C, Bailão AM, Borges CL, Pereira M, Soares CM, Mendes-Giannini MJ (2007) cDNA representational difference analysis used in the identification of genes expressed by Trichophyton rubrum during contact with keratin. Microbes Infect 9:1415-1421.
7. Balfour J. A, Faulds D (1992) Terbinafine A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 43:259-284.
8. Baranova Z., Kozak M, Bilek J (2003) Zoophilic dermatomycosis in a family caused by Trichophyton mentagrophytes var. quincheanum-A case report. Acta Vet Brno 72:311-314.
9. Brazil (2006) Ministry of Health SdC, Tecnology and Estrategic Inputs. National policy of medicinal plants and herbal medicine. In: Pharmaceuticals DDA editor, Brasilia.
10. Burmester A., Shelest E, Glöckner G, Heddergott C, Schindler S, Staib P., Heidel A, Felder M, Petzold A, Szafranski K, Feuermann M., Pedruzzi I, Priebe S, Groth M, Winkler R, Li W, Kniemeyer O, Schroeckh V, Hertweck C, Hube B, White TC, Platzer M, Guthke R, Heitman J, Wöstemeyer J, Zipfel PF, Monod M, Brakhage AA (2011) Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi. Genome Biol 12:R7.
11. Butler M. S (2005) Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 22:162-195.
12. Butler M. S (2005) Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 22:162-195.
13. Cabañes F. J (2000) Emerging mycotoxins: introduction. Rev. Iberoam. Micol 17:S61-S62.
14. Carrillo-Muñoz AJ, Giusiano G, Ezkurra PA, Quindós G (2006) Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter 19:130-139.
15. Cavaleiro C., Gonçalves MJ, Serra D, Santoro G, Tomi F, Bighelli A, Salgueiro L, Casanova J (2011) Composition of a volatile extract of Eryngium duriaei subsp. juresianum (M. Laínz) M. Laínz, signalised by the antifungal activity. J Pharm Biomed Anal 54:619-622.
16. Chin Y. W, Balunas MJ, Chai HB, Kinghorn AD (2006) Drug discovery from natural sources. AAPS Journal 8:E239-253.
17. Chuang P. H, Lee CW, Chou JY, Murugan M, Shieh BJ, Chen HM (2007) Anti-fungal activity of crude extracts and essential oil of Moringa oleifera Lam. Bioresour Technol 98:232-236.
18. Deacon J. W (1998) Introduction to modern mycology. 3a ed. Blackwell, Oxford.
19. Eisenberg D. M, Kessier RC, Foster C, Norlock FE, Calkins DR, Delbanco T. L (1993) Unconventional Medicine in the United States-Prevalence, Costs, and Patterns of Use. N Engl J Med 328:246-252.
20. Eisenberg D. M, Kessier RC, Foster C, Norlock FE, Calkins DR, Delbanco T. L (1993) Unconventional Medicine in the United States-Prevalence, Costs, and Patterns of Use. N Engl J Med 328:246-252.
21. Erbagci Z. (2004) Topical therapy for dermatophytoses: should corticosteroids be included?AmJ Clin Dermatol 5:375-384.
22. Espinel-Ingroff A (2008) Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol 25:101-106.
23. Fachin A. L, Ferreira-Nozawa MS, Maccheroni W, Martinez-Rossi NM (2006) Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum. J Med Microbiol 55:1093-1099.
24. Fernández-Torres B, Carrillo AJ, Martín E, Del Palacio A, Moore MK, Valverde A, Serrano M, Guarro J (2001) In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 45:2524-2528.
25. Fernández-Torres B, Inza I, Guarro J (2003) In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes. J Clin Microbiol 41:5209-5211.
26. Follador I., Bittencourt A, Duran F, das Graças Araújo MG (2001) Cutaneous protothecosis: report of the second Brazilian case. Rev Inst Med Trop São Paulo 43:287-290.
27. García-Sosa K, Sánchez-Medina A, Álvarez SL, Zacchino S, Veitch N. C, Simá-Polanco P, Peña-Rodriguez LM (2011) Antifungal activity of sakurasosaponin from the root extract of Jacquinia flammea. Nat Prod Res 25:1185-1189.
28. Gupta A. K, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, Aboobaker J., Summerbell RC (2001) Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin vs. the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 18:433-438.
29. Gupta A. K, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, Aboobaker J., Summerbell RC (2001) Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin vs. the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 18:433-438.
30. Gurgel L. A, Sidrim JJ, Martins DT, Cechinel Filho V, Rao VS (2005) In vitro antifungal activity of dragon's blood from Croton urucurana against dermatophytes. J Ethnopharmacol 97:409-412.
31. Harvey A. L (2007) Natural products as a screening resource. Curr Opin Chem Biol 11:480-484.
32. Kamai Y., Maebashi K, Kudoh M, Makimura K, Naka W, Uchida K, Yamaguchi H (2004) Characterization of mechanisms of fluconazole Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis. Microbiol Immunol 48:937-943.
33. Katzung G. B, Silva P, Mundim FD, Vooeux PJ (1998). Basic and clinical pharmacology. Editora Guanabara Koogan, Rio de Janeiro, Brazil.
34. Koroishi A. M, Foss SR, Cortez DA, Ueda-Nakamura T, Nakamura CV, Dias Filho BP (2008) In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes. J Ethnopharmacol 117:270-277.
35. Lau K. M, Fu LH, Cheng L, Wong CW, Wong YL, Lau CP, Han SQ, Chan PK, Fung KP, Lau CB, Hui M, Leung PC (2010) Two antifungal components isolated from Fructus Psoraleae and Folium Eucalypti Globuli by bioassayguided purification. Am J Chin Med 38:1005-1014.
36. Lima B., López S, Luna L, Agüero MB, Aragón L, Tapia A, Zacchino S., López ML, Zygadlo J, Feresin GE (2011). Essential oils of medicinal plants from the central andes of Argentina: chemical composition, and antifungal, antibacterial, and insect-repellent activities. Chem Biodivers 8:924-936.
37. Macêdo D. P, Neves RP, Neves RP, Magalhães MC, Souza-Motta CM., Queiroz LA (2005) Pathogenic aspects of Epidermophyton floccosum Langeron et Milochevich as a possible a ethiologial agent of Tinea capitis. Braz J Microbiol 36:36-37.
38. Machado K. E, Cechinel-Filho V, Cruz RC, Meyre-Silva C, Cruz AB (2009) Antifungal activity of Eugenia umbelliflora against dermatophytes. Nat Prod Commun 4:1181-1184.
39. Mancianti F., Pedonese F, Millanta F, Guarnieri L (1999) Efficacy of oral terbinafine in feline dermatophytosis due to Microsporum canis. J Feline Med Surg 1:37-41.
40. Maranhão F. C, Paião FG, Fachin AL, Martinez-Rossi NM (2009) Membrane transporter proteins are involved in Trichophyton rubrum pathogenesis. J Med Microbiol 58:163-168.
41. Martinez-Rossi NM, Peres NT, Rossi A (2008) Antifungal resistance mechanisms in dermatophytes. Mycopathologia 166:369-383.
42. McClellan KJ, Wiseman LR, Markham A (1999) Terbinafine. An update of its use in superficial mycoses. Drugs 58:179-202.
43. Monod M. (2008) Secreted proteases from dermatophytes. Mycopathologia 166:285-294.
44. Mukherjee P. K, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum M. A (2003) Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 47:82-86.
45. Newman D. J, Cragg, GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461-477.
46. Odds C. F (2003) Antifungal agents: Their diversity and increasing sophistication. Mycologist 17:51-55.
47. Oliveira J. S, Kerbauy FR, Colombo AL, Bahia DM, Pinheiro GS, Silva M. R, Ribeiro MS, Raineri G, Kerbauy J (2002) Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole. Braz J Med Biol Res 35:789-798.
48. Osborne C. S, Leitner I, Hofbauer B, Fielding CA, Favre B, Ryder NS (2006) Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine. Antimicrob Agents Chemother 50:2234-2236.
49. Park B. J, Taguchi H, Kamei K, Matsuzawa T, Hyon SH, Park JC (2011) In vitro antifungal activity of epigallocatechin 3-Ogallate against clinical isolates of dermatophytes. Yonsei Med J 52:535-538.
50. Pereira D. B, Meireles MCA (2001) Diseases caused by fungi and Oomycetes. Diseases of ruminants and horses 4:367-383.
51. Peres N. T, Maranhão FC, Rossi A, Martinez-Rossi NM (2010) Dermatophytes: host-pathogen interaction and antifungal resistance. An Bras Dermatol 85:657-667.
52. Pfaller M. A, Sutton DA (2006) Review of in vitro activity of sertaconazole nitrate in the treatment of superficial fungal infections. Diagn Microbiol Infect Dis 56:147-152.
53. Pinto E., Afonso C, Duarte S, Vale-Silva L, Costa E, Sousa E, PintoM(2011) Antifungal activity of xanthones: evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography. Chem Biol Drug Des 77:212-222.
54. Pinto E., Vale-Silva L, Cavaleiro C, Salgueiro L (2009) Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol 58:1454-1462.
55. Pisseri F., Bertoli A, Nardoni S, Pinto L, Pistelli L, Guidi G, Mancianti F. (2009) Antifungal activity of tea tree oil from Melaleuca alternifolia against Trichophyton equinum: an in vivo assay. Phytomedicine 16:1056-1058.
56. Ponnusamy K., Petchiammal C, Mohankumar R, Hopper W (2010) In vitro antifungal activity of indirubin isolated from a South Indian ethnomedicinal plant Wrightia tinctoria R. Br J Ethnopharmacol 132:349-354.
57. Queiroz E. F, Wolfender JL, Hostettmann K (2009) Modern approaches in the search for new lead antiparasitic compounds from higher plants. Current Drugs 10:202-211.
58. Rocha E. M, Gardiner RE, Park S, Martinez-Rossi NM, Perlin DS (2006) A Phe389Leu substitution in ergA confers terbinafine resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 50:2533-2536.
59. Rojas J. J, Ochoa VJ, Ocampo AS, Muñoz JF (2006) Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: a possible alternative in the treatment of non-nosocomial infections. BMC Complement Altern Med 17:2.
60. Sanguinetti M., Posteraro B, Romano L, Battaglia F, Lopizzo T, De Carolis E, Fadda G (2007) In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes. J Antimicrob Chemother 59:305-308.
61. Santos A. O, Ueda-Nakamura T, Dias Filho BP, Veiga Junior VF. Pinto A. C, Nakamura CV (2008) Antimicrobial activity of Brazilian copaiba oils obtained from different species of the Copaifera genus. Mem Inst Oswaldo Cruz 103:277-281.
62. Sidrim J. JC, Rocha MFG (2004) Medical Mycology light of authors contemporâneos. Guanabara Koogan. Rio de Janeiro, Brasil.
63. Silveira G. P, Nome F, Gesser JC, Sá MM, Terenzi T (2006) The strategies used to combat bacterial resistence. Química Nova 29:844-855.
64. Simões C. MO, Schenkel EP, Gosmann MG, Mello JCP, Ments LA, Petrovick PR (2003) Pharmacognosy: The medicinal plant-products of plant origin and development of drugs. 5a ed. p. 291-320.
65. Simpanya M. F (2000) Dermatophytes: Their taxonomy, ecology and pathogenicity. Rev Iberoam Micol 17:1-12.
66. Soares L. A (2011) Estudy of the activity antidermatiphytic of protocatechuate against T. rubrum and T. interdigitale. Araraquara, São Paulo, Brazil, 85 p. (M. Sc. Dissertation Faculty of Pharmaceutical Sciences: University Estadual Paulista Júlio Júlio Mesquita Filho-UNESP).
67. Sobestiansky J. (2001) Clinical and Swine Pathology e Patologia Suína. Goiania: Gráfica Art3. 2ed. p. 463.
68. Tani K., Adachi M, Nakamura Y, Kano R, Makimura K, Hasegawa A, Kanda N, Watanabe S (2007) The effect of dermatophytes on cytokine production by human keratinocytes. Arch Dermatol Res 299:381-387.
69. Weitzman I., Summerbell RC (1995) The dermatophytes. Clin Microbiol Rev 8:240-259.
70. White T. C, Oliver BG, Gräser Y, HennMR(2008) Generating and testing molecular hypotheses in the dermatophytes. Eukaryot Cell 7:1238-1245.
71. Wilson R. M, Danishefsky SJ (2006) Small molecule natural products in the discovery of therapeutic agents: the synthesis connection. J Org Chem 71:8329-8351.
72. Wojtaszek P. (1997) Oxidative burst: an early plant response to pathogen infection. Biochem J 322:681-692.
73. Yunes R. A, Calixto JB (2001) Plantas medicinais sob óptica da química medicinal moderna. 2001. Moderna-Chapecó: Argos.
74. Zomorodian K., Uthman U, Tarazooie B, Rezaie S (2007) The effect of griseofulvin on the gene regulation of beta-tubulin in the dermatophyte pathogen Trichophyton rubrum. J Infect Chemother 13:373-379.